Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating activities:      
Net (loss) income $ (127) $ 153 $ 523
Less: Loss (income) from discontinued operations, net of tax 27 (118) (12)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest (100) 35 511
Adjustments to reconcile (loss) income from continuing operations to net cash provided by operating activities from continuing operations:      
Equity in income of investment in unconsolidated affiliates (44) (83) (67)
Cash received from return on investment in unconsolidated subsidiary 101 59 71
Depreciation and amortization 289 278 281
Noncash lease expense 76 68 63
Gain on acquisition of assets, net (51) 0 0
Noncash prepaid asset write-off 71 0 0
Loss on dissolution of subsidiaries 39 [1] 0 0
Noncash restructuring and impairment charges 10 11 6
Deferred income taxes (15) (10) 89
Stock-based compensation 30 28 29
Other, net 9 24 (27)
Changes in operating assets and liabilities:      
Accounts and notes receivable 7 103 146
Inventories (77) 125 (6)
Receivable associated with the Albemarle Settlement 0 0 333
Prepaid expenses (34) 6 (6)
Other current assets 22 24 (38)
Other noncurrent assets (163) 60 (52)
Accounts payable 69 (224) (84)
Accrued liabilities 23 (31) (304)
Other noncurrent liabilities 23 (222) (53)
Net cash provided by operating activities from continuing operations 285 251 892
Net cash (used in) provided by operating activities from discontinued operations (22) (42) 22
Net cash provided by operating activities 263 209 914
Investing activities:      
Capital expenditures (184) (230) (272)
Cash received from return of investment in unconsolidated subsidiary 30 0 0
Cash received from sale of businesses, net 16 544 0
Cash received from sale of assets 11 0 0
Insurance proceeds for recovery of property damage 0 0 5
Other, net 1 (5) 7
Net cash (used in) provided by investing activities from continuing operations (126) 309 (260)
Net cash used in investing activities from discontinued operations 0 (4) (19)
Net cash (used in) provided by investing activities (126) 305 (279)
Financing activities:      
Net (repayments) borrowings on revolving loan facilities (169) (51) 219
Proceeds from long-term debt 349 0 0
Repayments of long-term debt (13) (11) (12)
Principal payments on note payable (218) 0 0
Dividends paid to common stockholders (174) (169) (171)
Distributions paid to noncontrolling interests (86) (36) (16)
Repurchase of common stock (4) (349) (1,005)
Repurchase and cancellation of stock awards (5) (10) (14)
Proceeds from issuance of common stock 0 5 6
Other, net (6) 1 (1)
Net cash used in financing activities (326) (620) (994)
Effect of exchange rate changes on cash (11) (8) (28)
Decrease in cash and cash equivalents (200) (114) (387)
Cash and cash equivalents at beginning of period 540 654 1,041
Cash and cash equivalents at end of period 340 540 654
Supplemental cash flow information:      
Cash paid for interest 77 68 66
Cash paid for income taxes 90 97 194
Huntsman International LLC [Member]      
Operating activities:      
Net (loss) income (125) 155 524
Less: Loss (income) from discontinued operations, net of tax 27 (118) (12)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest (98) 37 512
Adjustments to reconcile (loss) income from continuing operations to net cash provided by operating activities from continuing operations:      
Equity in income of investment in unconsolidated affiliates (44) (83) (67)
Cash received from return on investment in unconsolidated subsidiary 101 59 71
Depreciation and amortization 289 278 281
Noncash lease expense 76 68 63
Gain on acquisition of assets, net (51) 0 0
Noncash prepaid asset write-off 71 0 0
Loss on dissolution of subsidiaries 39 [1] 0 0
Noncash restructuring and impairment charges 10 11 6
Deferred income taxes (16) (10) 91
Other, net 7 23 (25)
Noncash compensation 29 27 27
Changes in operating assets and liabilities:      
Accounts and notes receivable 7 103 146
Inventories (77) 125 (6)
Receivable associated with the Albemarle Settlement 0 0 333
Prepaid expenses (34) 6 (8)
Other current assets 27 25 (43)
Other noncurrent assets (163) 60 (52)
Accounts payable 69 (223) (84)
Accrued liabilities 20 (31) (297)
Other noncurrent liabilities 23 (222) (53)
Net cash provided by operating activities from continuing operations 285 253 895
Net cash (used in) provided by operating activities from discontinued operations (22) (42) 22
Net cash provided by operating activities 263 211 917
Investing activities:      
Capital expenditures (184) (230) (272)
Cash received from return of investment in unconsolidated subsidiary 30 0 0
Cash received from sale of businesses, net 16 544 0
Cash received from sale of assets 11 0 0
Insurance proceeds for recovery of property damage 0 0 5
Other, net 2 (4) 7
Net cash (used in) provided by investing activities from continuing operations (138) (42) (1,277)
Net cash used in investing activities from discontinued operations 0 (4) (19)
Net cash (used in) provided by investing activities (138) (46) (1,296)
Increase in receivable from affiliate (13) (352) (1,017)
Financing activities:      
Net (repayments) borrowings on revolving loan facilities (169) (51) 219
Proceeds from long-term debt 349 0 0
Repayments of long-term debt (13) (11) (12)
Principal payments on note payable (218) 0 0
Distributions paid to noncontrolling interests (86) (36) (16)
Other, net (5) (1) (1)
Net cash used in financing activities (314) (271) 22
Effect of exchange rate changes on cash (11) (8) (28)
Decrease in cash and cash equivalents (200) (114) (385)
Cash and cash equivalents at beginning of period 540 654 1,039
Cash and cash equivalents at end of period 340 540 654
Dividends paid to parent (172) (172) (168)
Supplemental cash flow information:      
Cash paid for interest 77 68 66
Cash paid for income taxes $ 90 $ 97 $ 194
[1] Loss on dissolution of subsidiaries for the year ended December 31, 2024 relates to the elimination and non-cash recognition of cumulative translation adjustments from accumulated other comprehensive loss due to the liquidation of certain subsidiaries.